Literature DB >> 23105822

MTHFR (Ala 222 Val) polymorphism and AMI in patients with type II diabetes mellitus.

T Angeline1, G Thiruvarutselvi, W Isabel, Rita Mary Aruna, Rama Devi, Nirmala Jeyaraj.   

Abstract

The prevalent Ala222Val single nucleotide polymorphism of the MTHFR gene has been shown to be associated with type II diabetes. The objective of the present study was to find out whether there is genetic predisposition for development of acute myocardial infarction in type II diabetes mellitus among South Indian Tamil population. PCR-based restriction enzyme analysis was performed in DNA isolated from 120 acute myocardial infarction patients with diabetes mellitus and 100 non diabetic healthy individuals with no documented cardiovascular diseases. The results indicate that the MTHFR 677TT genotype is absent in both case and controls. The MTHFR 677CT genotype was observed among 32 (26.7 %) cases and 20 (20%) controls and the MTHFR 677CC genotype among 88 (73.3%) cases and 80 (80%) controls. The allelic frequencies were in accordance to Hardy Weinberg equilibrium. There was no statistical difference in genotype distribution between cases and controls. In conclusion, we suggest that the analysis of MTHFR genotyping for C677T polymorphism alone need not be considered to find out whether there is genetic predisposition for development of acute myocardial infarction in type II diabetes mellitus among South Indian Tamil population.

Entities:  

Keywords:  Acute Myocardial Infarction; Genetic predisposition; MTHFR gene; Polymorphism; Type II diabetes

Year:  2009        PMID: 23105822      PMCID: PMC3453219          DOI: 10.1007/s12291-009-0025-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

1.  Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.

Authors:  H Morita; J Taguchi; H Kurihara; M Kitaoka; H Kaneda; Y Kurihara; K Maemura; T Shindo; T Minamino; M Ohno; K Yamaoki; K Ogasawara; T Aizawa; S Suzuki; Y Yazaki
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus.

Authors:  M T Agulló-Ortuño; M D Albaladejo; S Parra; M Rodríguez-Manotas; M Fenollar; F Ruíz-Espejo; J Tebar; P Martínez
Journal:  Clin Chim Acta       Date:  2002-12       Impact factor: 3.786

3.  Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations.

Authors:  P A Isotalo; G A Wells; J G Donnelly
Journal:  Am J Hum Genet       Date:  2000-08-24       Impact factor: 11.025

4.  The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients.

Authors:  V Shpichinetsky; I Raz; Y Friedlander; N Goldschmidt; I D Wexler; A Ben-Yehuda; G Friedman
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

5.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations.

Authors:  G Friedman; N Goldschmidt; Y Friedlander; A Ben-Yehuda; J Selhub; S Babaey; M Mendel; M Kidron; H Bar-On
Journal:  J Nutr       Date:  1999-09       Impact factor: 4.798

6.  Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos.

Authors:  Henrik Zetterberg; Björn Regland; Mona Palmér; Anne Ricksten; Lars Palmqvist; Lars Rymo; Demetrios A Arvanitis; Demetrios A Spandidos; Kaj Blennow
Journal:  Eur J Hum Genet       Date:  2002-02       Impact factor: 4.246

7.  The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.

Authors:  Piotr Ksiazek; Anna Bednarek-Skublewska; Monika Buraczyńska
Journal:  Med Sci Monit       Date:  2004-02

8.  Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus.

Authors:  Hulya Yilmaz; Bedia Agachan; Arzu Ergen; Zeynep Ermis Karaalib; Turgay Isbir
Journal:  J Biochem Mol Biol       Date:  2004-03-31

9.  MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.

Authors:  Makiko Maeda; Isamu Yamamoto; Masakatsu Fukuda; Mari Nishida; Junko Fujitsu; Shinpei Nonen; Tsuyoshi Igarashi; Takashi Motomura; Makiko Inaba; Yasushi Fujio; Junichi Azuma
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.

Authors:  Jiazhong Sun; Yancheng Xu; Yilian Zhu; Hongyun Lu
Journal:  Diabetes Res Clin Pract       Date:  2004-06       Impact factor: 5.602

View more
  2 in total

1.  Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.

Authors:  Tao Huang; JingJing Ren; Jinyan Huang; Duo Li
Journal:  BMC Genomics       Date:  2013-12-10       Impact factor: 3.969

2.  Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms and associated risk of cardiovascular diseases: A study from Jammu region.

Authors:  Jyotdeep K Raina; Minakashee Sharma; Rakesh K Panjaliya; Minakshi Bhagat; Ravi Sharma; Ashok Bakaya; Parvinder Kumar
Journal:  Indian Heart J       Date:  2016-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.